In order to evaluate SALL4 implication in BC patient survival, we analyzed the overall survival (OS) and distant metastasis-free survival (DMFS) in all types of BC (ALL) and, specifically, in the HER2+ BC subtype related to this gene expression. This evidence concerns the gene ERBB2 and acute lymphoblastic leukemia.